French preclinical CRO NovAliX has found a new partner across the pond. Massachusetts-based manufacturer Bruker Corporation has announced a minority investment in the CRO. “This partnership with ...
Many biological functions are regulated by the switching on and off of mechanisms triggered by the matching of a keyhole ...
Figure 1. This figure depicts the four categories of protein druggability target screening tools discussed in this section, which include structure-based methods, sequence-based methods, machine ...
Advancing the Discovery of Novel Therapies and Building an Integrated Drug Discovery Platform by Combining PPI Science with AI - ...
New South San Francisco center showcases how cutting-edge cryo-electron microscopy is transforming and accelerating drug ...
The MarketWatch News Department was not involved in the creation of this content. Advancing proprietary AI discovery of high-bioavailability Oral GLP-1 drug candidates. HOUSTON, Feb. 3, 2026 ...
In drug discovery, virtual screening is a fast and cost-effective way of narrowing down vast chemical libraries to identify the most promising hits, reducing synthesis and testing requirements while ...
Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than toxic chemicals—a discovery that could accelerate and improve how medicines ...
This article is based on a poster originally authored by Daniel A. Barr, Mario Öeren, Peter A. Hunt, Jonathan D. Tyzack, Tomáš Chrien, Tamsin E. Mansley and Matthew D. Segall, which was presented at ...
Advancing proprietary AI discovery of high-bioavailability Oral GLP-1 drug candidates. HOUSTON, Feb. 3, 2026 /PRNewswire/ -- Deep EigenMatics, Inc., a pioneer in high-velocity Artificial Intelligence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results